Comparator sourcing may be the most expensive blind spot in clinical trials, driving massive waste, delays, shortages, and operational risk.
- U.S. Policy Drift And The Shift In Clinical Trial Supply Leadership
- The Hidden Operational Complexities Of Home Infusion
- Building Resilient Clinical Trial Supply Chains In An Era Of Geopolitical Risk
- Site-Level Execution In Clinical Trials: Where Systems Break Down
- Blind Spots And Blocked Ports: Surviving Clinical Supply Friction In LATAM And APAC
- Truth: Clinical Supply Is Often The First To See The Whole Picture
- The $122 Billion Question: Can Clinical Trial Supply Systems Keep Pace With Cell Therapy Demand?
- From Individual Shipments To Patterns: How Compliance Is Understood Over Time
ON-DEMAND WEBINARS
See how study characteristics, regulatory landscapes, and business priorities combine to inform clinical supply placement decisions between EU and non-EU European locations.
Watch as industry experts explore the advancements in drug accountability facilitated through IRT, encompassing innovative methods for managing site variations and sustainable supply chains.
Individual data points over time can provide precise drug dosing histories that enable better understanding of protocol adherence, safety, efficacy, PK/PD and a drug’s exposure-response relationship.
Learn how demand-led and hybrid clinical supply models reduce waste, accelerate timelines, and improve flexibility for global trials through regional hubs and patient-specific packaging strategies.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![Supply Chain - Getty- 1159559071]( "European Clinical Supply Planning – Balancing Cost, Flexibility, And Time")
European Clinical Supply Planning – Balancing Cost, Flexibility, And TimeBy evaluating the key parameters of a study, sponsors can identify the most effective location for packaging and distributing clinical trial supplies.
-
![iStock-1277730987-supply-chain-logistics-tracking-sourcing]( "Planning For The Return And Destruction Of Your Product")
Planning For The Return And Destruction Of Your ProductAspects of accountability, reconciliation, return, and destruction require significant effort to compile historical data. A little up-front planning can remove many future complications.
-
![GettyImages-1391646149 technology]( "Providing Drug Supply Support In Complex Environments Through IRT")
Providing Drug Supply Support In Complex Environments Through IRTLearn how applying predictive data analytics can enable the creation of an ideal supply strategy capable of reducing the need for extra shipments, manual oversight, and supply waste.
-
![gettyimages-871704288-170667a]( "The Patient-Centric Clinical Supply Chain For Cell And Gene Therapies")
The Patient-Centric Clinical Supply Chain For Cell And Gene TherapiesThis article explores how delivering cell and gene therapies to patients requires new levels of agility, flexibility and innovation in the logistical management of supply.
-
![analytical-timelines-GettyImages-2247278213]( "Compressing Analytical Timelines Without Cutting Corners")
Compressing Analytical Timelines Without Cutting CornersEfficient analytical development speeds decisions and improves risk visibility. Using QbD, digital tools, and strong communication helps teams accelerate timelines while maintaining rigor.
-
![03 West]( "Sample Sizes For Performance Testing Of Combination Products, Packaging")
Sample Sizes For Performance Testing Of Combination Products, PackagingWhen developing combination products or evaluating primary packaging for drug products one must evaluate the performance of the devices and the packaging to ensure that they are fit-for-purpose.
-
![Future Technology Science]( "Effective Use Of IRT In Decentralized And Hybrid Clinical Trials")
Effective Use Of IRT In Decentralized And Hybrid Clinical TrialsUncover the ways interactive response technologies are helping trial sponsors manage the distribution of medications, forecast trial supply, and integrate workflows with other technology platforms.
-
![West_GCApp_MG (person picking up container)]( "Understanding Injectable Drug Container Closure Systems")
Understanding Injectable Drug Container Closure SystemsChoosing the right container closure system (CCS) format is crucial, so understanding the different parts involved, their functions, storage requirements, and how they impact administering the drug is essential.
-
![GettyImages-1184502868 oncology patient]( "Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial")
Emerging Biopharm Rapidly Sets Up Phase 1 Oncology TrialUncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.
-
![accuracy-in-drug-development-GettyImages-2249698250]( "GMP Clinical Storage Strategies for Today's Complex Trials")
GMP Clinical Storage Strategies for Today's Complex TrialsTemperature‑sensitive therapies need more than basic freezer space. Purpose‑built GMP storage protects product integrity, supports compliance, and adds flexibility as trial complexity grows.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
